Mount Yale Investment Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$987K Buy
4,154
+2,241
+117% +$466K 0.02% 587
2026
Q1
$404K Buy
1,913
+572
+43% +$123K 0.01% 783
2025
Q4
$276K Sell
1,341
-136
-9% -$25.6K 0.01% 609
2025
Q3
$232K Sell
1,477
-2,603
-64% -$402K 0.02% 592
2025
Q2
$685K Buy
+4,080
New +$606K 0.05% 277
2018
Q4
Sell
-2,379
Closed -$128K 385
2018
Q3
$128K Sell
2,379
-1,213
-34% -$62.1K 0.02% 366
2018
Q2
$175K Buy
3,592
+1,421
+65% +$80.6K 0.03% 317
2018
Q1
$136K Buy
+2,171
New +$149K 0.03% 368

Other funds holding CAH

Mount Yale Investment Advisors's CAH Position: Q2 2026 in Review

Mount Yale Investment Advisors increased its Cardinal Health (CAH) stake by 117% in Q2 2026, buying an estimated $466K and bringing the position to 4,154 shares worth $987K. The position accounts for 0.02% of the portfolio, ranked #587.

Mount Yale Investment Advisors first reported a position in CAH in Q1 2018 and has held it in 8 quarters since. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Mount Yale Investment Advisors held 4,154 shares of Cardinal Health worth $987K as of Q2 2026.
  • Mount Yale Investment Advisors bought 2,241 Cardinal Health shares in Q2 2026, an estimated $466K.
  • Cardinal Health made up 0.02% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #587 holding.
  • Mount Yale Investment Advisors first reported a position in Cardinal Health in Q1 2018 and has held it in 8 quarters since.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.